3rd Quarter - Termination

AVENUE STRATEGIES for ARCTURUS THERAPEUTICS, INC.

Firm
Client
Income
$100,000
Expenses
—
Terminated
Jul 13, 2020

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Arcturus Therapeutics' technology and science as a potential solution to limit the spread and adverse effects of the COVID-19 virus

LobbyistCovered position, as disclosed
BARRY BENNETT Chief of Staff, Rep. Jean Schmidt, 2005-10; Communications Director, G8 Summit, State Dept., 2003-04

Contacted: White House Office; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.